Stone Ridge Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Stone Ridge Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-65,585	Closed	-$4.21M	–	758
2019 Q4	$4.21M	Buy	65,585 +20,200	+45%	+$1.16M	0.25%	64
2019 Q3	$2.3M	Sell	45,385 -89,500	-66%	-$4.21M	0.14%	176
2019 Q2	$6.12M	Buy	134,885 +13,900	+11%	+$647K	0.36%	47
2019 Q1	$5.77M	Buy	120,985 +19,200	+19%	+$956K	0.33%	49
2018 Q4	$5.29M	Buy	101,785 +19,779	+24%	+$1.06M	0.32%	39
2018 Q3	$5.09M	Buy	82,006 +5,890	+8%	+$350K	0.27%	57
2018 Q2	$4.21M	Buy	76,116 +9,312	+14%	+$503K	0.24%	80
2018 Q1	$4.22M	Hold	66,804	–	–	0.25%	66
2017 Q4	$4.09M	Buy	+66,804	New	+$4.18M	0.26%	60
2016 Q1	–	Sell	-3,100	Closed	-$213K	–	62
2015 Q4	$213K	Sell	3,100 -2,500	-45%	-$165K	0.72%	74
2015 Q3	$332K	Buy	5,600 +1,500	+37%	+$95.2K	1.31%	12
2015 Q2	$273K	Hold	4,100	–	–	0.63%	48
2015 Q1	$264K	Hold	4,100	–	–	0.66%	60
2014 Q4	$242K	Buy	+4,100	New	+$231K	0.51%	83

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stone Ridge Asset Management's BMY Position: Q1 2020 in Review

Stone Ridge Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 65,585 shares — an estimated $4.21M sold.

Stone Ridge Asset Management first reported a position in BMY in Q4 2014 and held it in 14 quarters. The position peaked at $6.12M in Q2 2019. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

Stone Ridge Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 65,585 Bristol-Myers Squibb shares in Q1 2020, an estimated $4.21M.
Stone Ridge Asset Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 14 quarters.
Stone Ridge Asset Management's Bristol-Myers Squibb position peaked at $6.12M in Q2 2019.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Stone Ridge Asset Management's 13F filing for Q1 2020, filed 5 May 2020.